Bayer is forced to release documents over withdrawal of cerivastatin.
Marwick
Charles
C
D030881:Disclosure; D004345:Drug Industry / Q000331:legislation & jurisprudence*; D004335:Drug and Narcotic Control; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000009:adverse effects; D011725:Pyridines / Q000009:adverse effects; D012206:Rhabdomyolysis / Q000139:chemically induced; D014481:United States
D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D011725:Pyridines; C086276:cerivastatin